semaglutide japan Sumitomo, Novo Nordisk to co-promote obesity drug Wegovy in BioWorld

doi: 10.1007/7854_2016_40 76 HayesM

What women reported: 57% said their cycles became more regular 24% reported lighter periods Around 13% experienced more irregular cycles, heavier periods, or missed periods Some things improved, some got worse. Mira survey participant What this means GLP-1 medications may influence hormonal patterns but effects move in different directions and outcomes are not uniform

Individual tolerance varies widelysome patients tolerate all foods comfortably, while others need strict restrictions

Be sure to talk to your team of healthcare providers for guidance on whether these medications are right for you

All compounds mentioned are for laboratory research use only and are not intended for human consumption